IL155819A0 - Methods of treatment comprising administration of substance p - Google Patents

Methods of treatment comprising administration of substance p

Info

Publication number
IL155819A0
IL155819A0 IL15581901A IL15581901A IL155819A0 IL 155819 A0 IL155819 A0 IL 155819A0 IL 15581901 A IL15581901 A IL 15581901A IL 15581901 A IL15581901 A IL 15581901A IL 155819 A0 IL155819 A0 IL 155819A0
Authority
IL
Israel
Prior art keywords
administration
substance
treatment
methods
Prior art date
Application number
IL15581901A
Other languages
English (en)
Original Assignee
Milkhaus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Lab Inc filed Critical Milkhaus Lab Inc
Publication of IL155819A0 publication Critical patent/IL155819A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046Tachykinins, e.g. eledoisins, substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15581901A 2000-11-28 2001-07-06 Methods of treatment comprising administration of substance p IL155819A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/723,699 US6437093B1 (en) 2000-11-28 2000-11-28 Methods of treatment comprising administration of Substance P
PCT/US2001/021414 WO2002043748A1 (en) 2000-11-28 2001-07-06 Methods of treatment comprising administration of substance p

Publications (1)

Publication Number Publication Date
IL155819A0 true IL155819A0 (en) 2003-12-23

Family

ID=24907313

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15581901A IL155819A0 (en) 2000-11-28 2001-07-06 Methods of treatment comprising administration of substance p

Country Status (7)

Country Link
US (2) US6437093B1 (ja)
EP (1) EP1337265A4 (ja)
JP (1) JP3916563B2 (ja)
AU (1) AU2001273228A1 (ja)
CA (1) CA2428026A1 (ja)
IL (1) IL155819A0 (ja)
WO (1) WO2002043748A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437093B1 (en) * 2000-11-28 2002-08-20 Milkhaus Laboratory, Inc. Methods of treatment comprising administration of Substance P
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 p 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
AU2007221135A1 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2013119042A1 (en) * 2012-02-09 2013-08-15 University-Industry Cooperation Group Of Kyung Hee University Composition for preventing or curing neuropathic pain comprising substance-p
DE102014200499B4 (de) * 2014-01-14 2017-03-30 Robert Bosch Gmbh Mikrofluidisches System sowie Vorrichtung und Verfahren zum Leiten von Fluid in einem mikrofluidischen System

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059693A (en) * 1976-06-11 1977-11-22 University Patents, Inc. Analgesic action of substance P
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
US5616562A (en) * 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
US5137873A (en) * 1990-07-27 1992-08-11 The Children's Medical Center Corporation Substance p and tachykinin agonists for treatment of alzheimer's disease
US5420297A (en) 1990-10-24 1995-05-30 Fujisawa Pharmaceutical Co., Ltd. Peptides having substance P antagonistic activity
US5891842A (en) * 1993-04-09 1999-04-06 Trustees Of Tufts College Methodology for eliciting an analgesic response in a living subject
US5945508A (en) * 1996-07-23 1999-08-31 Witten; Mark L. Substance P treatment for immunostimulation
US6063758A (en) * 1997-07-09 2000-05-16 Advanced Targeting Systems, Inc. Substance P-Saporin (SP-SAP) conjugates and methods of use thereof
US6437093B1 (en) * 2000-11-28 2002-08-20 Milkhaus Laboratory, Inc. Methods of treatment comprising administration of Substance P

Also Published As

Publication number Publication date
US20030064932A1 (en) 2003-04-03
EP1337265A1 (en) 2003-08-27
EP1337265A4 (en) 2004-01-14
WO2002043748A1 (en) 2002-06-06
JP3916563B2 (ja) 2007-05-16
US6437093B1 (en) 2002-08-20
JP2004514698A (ja) 2004-05-20
CA2428026A1 (en) 2002-06-06
AU2001273228A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU6159901A (en) Surface treatment of medical device
AU5977401A (en) Delivery devices for treatment of vascular disease
EP1267798A4 (en) TREATMENT OF SKIN DAMAGE WITH POLYENYLPHOSPHATIDYLCHOLINE
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB0015745D0 (en) Treatment of bone diseases
AU7863201A (en) Treatment of hyperproliferative diseases
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0001710D0 (en) Therapeutic treatment
IL155819A0 (en) Methods of treatment comprising administration of substance p
GB2360453B (en) Treatment of skin conditions
AU2096002A (en) Therapeutic treatment
IL154011A0 (en) Treatment of wounds
GB0008921D0 (en) Method of treatment
GB9906808D0 (en) Formulation for treatment of pain
GB2381455B (en) Treatment of burns
EP1303281A4 (en) METHODS OF TREATMENT
AU6106801A (en) Trans-clitoral administration of therapy
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment
AU6884801A (en) Therapeutic compounds and methods
GB0010124D0 (en) Administration of beneficial substances

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees